314 - Ceftazidime-Avibactam Versus Meropenem-Vaborbactam for the Treatment of Carbapenem-Resistant Enterobacterales Infections

Presenting Author(s)

• 

  Sara M. Karaba, MD, PhD, MHS

  Assistant Professor
  Johns Hopkins University
  Baltimore, MD, United States

  Slides

Co-Author(s)

• 

  Dariusz A. Hareza, MD (he/him/his)

  Infectious Diseases Fellow
  Johns Hopkins University
  Baltimore, Maryland, United States
• 

  Armani Hawes, MD

  Resident Physician
  Johns Hopkins Hospital
  Baltimore, Maryland, United States
• YB

  Yehudit Bergman, MS

  Johns Hopkins
  Baltimore, Maryland, United States
• SF

  Suiyini Fiawoo, MD/MHS

  Postdoctoral Research Fellow
  Johns Hopkins School of Medicine
  Baltimore, Maryland, United States
• JL

  Jae Hyoung Lee, MD

  Johns Hopkins
  Baltimore, Maryland, United States
• 

  Sara E. Cosgrove, MD, MS

  Professor of Medicine
  Johns Hopkins School of Medicine
  Baltimore, MD, United States
• 

  Patricia J. Simner, PhD

  Associate Professor, Director of Bacteriology
  Johns Hopkins School of Medicine
  Baltimore, MD, United States
• 

  Pranita Tamma, MD, MHS

  Associate Professor
  Johns Hopkins School of Medicine
  Baltimore, MD, United States